New biomarkers for acute kidney injury (AKI) have improved our understanding of the etiology and pathogenesis of AKI. Depending on their origin, function, and kinetic profile, biomarkers have a role in screening, diagnosis, prognostication, and monitoring of AKI. This offers opportunities to improve the management of AKI, but concerns and limitations remain. In this review, we summarize the current role of new AKI biomarkers in the management of AKI and outline some of the ongoing limitations and challenges.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9216309 | PMC |
| http://dx.doi.org/10.1159/000518365 | DOI Listing |
Publication Analysis
Top Keywords
management aki
12
aki
7
biomarker-based management
4
aki fact
4
fact fantasy?
4
fantasy? biomarkers
4
biomarkers acute
4
acute kidney
4
kidney injury
4
injury aki
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!